reports
- Benjaphol Suthwanish
- Greater China Research Team
- Guan An Tan
- Johnny Yum
- Jonathan Koh
- Keith Wee Teck Keong
- Kitpon Praipaisarnkit
- Krit Tanarattananon
- Philip Wong
- Roy Chen Chengzhi
- Thailand Research Team
Regional Morning Meeting Notes: Tuesday, May 06, 2025
GREATER CHINA Strategy Alpha Picks: May Conviction Calls Add Alibaba, Innovent, Shuanghuan, Trip.com to our BUY list. Take profit on JBM Healthcare and CR Land. Sector Aviation Airlines: 1Q25 results below expectations. Weak fuel prices to support full-year performance. Maintain UNDERWEIGHT. INDONESIA Strategy 1Q25 Results Recap ...
BJC BERLI JUCKER PUBLIC CO. LTD.
A0M4P7 HAN'S LASER TECHNOLOGY INDUSTRY GROUP CO. LTD. CLASS A
00016 SUN HUNG KAI PROPERTIES LIMITED
00291 CHINA RESOURCES BEER (HOLDINGS) CO. LTD.
1023 CIMB GROUP HOLDINGS BHD
ERW ERAWAN GROUP
ADVANC ADVANCED INFO SERVICE PUBLIC CO. LTD.
MINT MINOR INTERNATIONAL PUBLIC CO. LTD.
PTTEP PTT EXPLORATION & PRODUCTION PLC
002472 ZHEJIANG SHUANGHUAN DRIVELINE (A)
CPN CENTRAL PATTANA PUBLIC CO. LTD.
BCH BANGKOK CHAIN HOSPITAL PCL
AD2 AIR CHINA LIMITED CLASS H
1055 CHINA SOUTHERN AIRLINES COMPANY LIMITED CLASS H
0670 CHINA EASTERN AIRLINES CORPORATION LIMITED CLASS H
01810 XIAOMI CORP. CLASS B
MTC MUANGTHAI CAPITAL PCL
RATCH RATCH GROUP PUBLIC CO. LTD.
01801 INNOVENT BIOLOGICS INC.
MRDIY MR DIY GROUP M BHD
09988 ALIBABA GROUP HOLDING LTD.
TIDLOR NGERN TID LOR PCL
002920 HUIZHOU DESAY SV AUTOMOTIVE CO LTD
02618 JD LOGISTICS INC
MXNU ELITE COMMERCIAL REIT MGNT PTE LTD
09961 CTRIP.COM INTERNATIONAL
BTG BETAGRO PUBLIC COMPANY LIMITED
- Benjaphol Suthwanish
Bangkok Dusit Medical Services (BDMS TB) - Expect A Healthy Growth In ...
BDMS should report a net profit of Bt4.3b in 1Q25 (+6.7% yoy, +0.3% qoq). The key contributions are from improving growth of Thai patient numbers and a strong growth from foreign patient numbers, especially from China and the Middle East. The earthquake in Myanmar could slow down the growth of patient volume from Myanmar in the near term, but we may see pent-up demand that could enhance BDMS’ earnings in 3Q25 and 4Q25. Maintain BUY. Target price: Bt33.00.
- Benjaphol Suthwanish
- Kasemsun Koonnara
Thailand Daily - Wednesday, April 23, 2025
KEY HIGHLIGHTS Update Bangkok Dusit Medical Services (BDMS TB/BUY/Bt23.50/Target: Bt33.00) Expect a healthy growth in 1Q25. Central Pattana (CPN TB/BUY/Bt48.50/Target: Bt79.60) Expect 1Q25 earnings to be stable yoy; resilient core business performance. PTT Global Chemical (PTTGC TB/BUY/Bt18.20/Target: Bt21.00) 1Q25 loss projected to decline qoq.
- Benjaphol Suthwanish
- Carol Dou Xiao Qin
- Colin Lee
- Desmond Chong Chee Wai
- Heidi Mo Jinghui
- John Cheong Ming Chern
- Johnny Yum Chung Man
- Julia Pan Mengyao
- Kasemsun Koonnara
- Ming San Soong
- Paula Ruth
- Philip Wong
- Sunny Chen
- Tanaporn Visaruthaphong
Regional Morning Meeting Notes: Wednesday, April 23, 2025
GREATER CHINA Initiate Coverage Tencent Music Entertainment Group (1698 HK/BUY/HK$47.80/Target: HK$60.00) World’s largest music platform with evolving social ecosystem. Results Dian Diagnostics (300244 CH/HOLD/Rmb13.99/Target: Rmb15.00) 2024: Results in line; maintain 2025 revenue growth estimate of 8.8% yoy. iFlytek (002230 CH/SELL/Rmb45.18/Target: Rmb35.00) 2024 and 1Q25: Earnings miss on heightened R&D spending; solid top-line growth. Update Sunn...
0166 INARI AMERTRON
SXC SUNNY OPTICAL TECHNOLOGY (GROUP) CO. LTD.
002230 IFLYTEK CO. LTD. CLASS A
7160 PENTAMASTER CORP. BHD
NANO NANOCO GROUP
0097 VITROX
PTTGC PTT GLOBAL CHEMICAL PUBLIC COMPANY LTD
CPN CENTRAL PATTANA PUBLIC CO. LTD.
TLKM PT TELKOM INDONESIA (PERSERO) TBK CLASS B
VSI V.S. INDUSTRY BERHAD
SKP SKP RESOURCES BHD
GREATEC GREATECH TECHNOLOGY BHD
CORAZA CORAZA INTEGRATED TECHNOLOGY BERHAD
NATGATE NATIONGATE HOLDINGS BHD
OPPSTAR OPPSTAR BERHAD
300244 DIAN DIAGNOSTICS GROUP CO
0303 ALPHA IVF GROUP
NE NORTHEAST GROUP BHD (NE MK)
1698 HK TENCENT MUSIC ENTERTAINMENT GROUP
Bangkok Dusit Medical Services Public Company Limited: 1 director
A director at Bangkok Dusit Medical Services Public Company Limited bought 1,000,000 shares at 22.440THB and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company'...
- Benjaphol Suthwanish
Bangkok Dusit Medical Services (BDMS TB) - Slow But Steady Growth Goin...
The tone at BDMS’ 4Q24 analyst meeting was neutral. BDMS guided a less aggressive growth target for 2025 due to concerns about the persistent sluggish outlook on Thai patients while maintaining an optimistic outlook on foreign patients. There are new expansions that will benefit BDMS in the long term, and the outlook for 1Q25 appears decent as we are seeing a strong growth in foreign patient numbers coupled with a boost from the influenza outbreak. Maintain BUY. Target price: Bt33.00.
- Benjaphol Suthwanish
- Adrian Loh Tzum Yung
- Bella Lu Yifei
- Benjaphol Suthwanish
- Damon Shen
- Jack Goh Tooan Orng
- Jieqi Liu
- Ken Lee
- Paula Ruth
Regional Morning Meeting Notes: Wednesday, March 12, 2025
GREATER CHINA Sector Property Shenzhen and Guangzhou seeing notable improvement in demand-supply dynamics. Results ECARX Holdings Inc (ECX US/BUY/US$2.67/Target: US$3.40) 4Q24: Net loss narrows due to revenue growth. Maintain BUY. Target price: US$3.40. INDONESIA Update XL Axiata (EXCL IJ/BUY/Rp2,260/Target: Rp3,300) XLSmart estimates potential cost synergies of US$300-...
00688 CHINA OVERSEAS LAND & INVESTMENT LIMITED
5168 HARTALEGA HOLDINGS BHD.
01109 CHINA RESOURCES LAND LIMITED
SCNR SUNAC CHINA HOLDINGS LTD.
RLF LONGFOR GROUP HOLDINGS LTD.
7113 TOP GLOVE CORPORATION BHD.
7153 KOSSAN RUBBER INDUSTRIES BHD.
D01 DAIRY FARM INTERNATIONAL HOLDINGS LIMITED
EXCL XL AXIATA TBK PT
ECX ECARX HOLDINGS INC
- Benjaphol Suthwanish
Bangkok Dusit Medical Services (BDMS TB) - 4Q24: Robust Quarterly Earn...
BDMS reported another robust quarterly net profit of Bt4.3b in 4Q24 (+9.6% yoy, +2.0% qoq), in line with our estimates but above consensus expectations. The growth from Thai patients is weak due to a sluggish economic outlook, while the growth from international patients remains strong. We are optimistic on the 1Q25 outlook as the number of influenza cases continues to rise. Maintain BUY. Target price: Bt33.00.
- Kampon Akaravarinchai
- Kasemsun Koonnara
- Thanawat Thangchadakorn
Thailand Daily - Thursday, February 27, 2025
KEY HIGHLIGHTS Results Betagro (BTG TB/BUY/Bt18.50/Target: Bt24.20) 4Q24: Earnings in line; expect stronger 1Q25 earnings. Bangkok Dusit Medical Services (BDMS TB/BUY/Bt26.50/Target: Bt33.00) 4Q24: Robust quarterly earnings; in line. Land and Houses (LH TB/HOLD/Bt4.54/Target: Bt5.20) 4Q24: One-off items underpinned performance; residential business remains weak. Srisawad Corporation (SAWAD TB/HOLD/Bt40.50/Target: Bt38.00) 4Q24: Results mis...
- Adrian Loh Tzum Yung
- Benjaphol Suthwanish
- Chong Lee Len
- Claire Wang Kelai
- Colin Lee
- Damon Shen
- Ejann Hiew
- Heidi Mo Jinghui
- Jo Yee Ng
- John Cheong Ming Chern
- Johnny Yum Chung Man
- Jonathan Koh
- Kampon Akaravarinchai
- Keith Wee Teck Keong
- Shirley Wang Xueyi
- Stella Guo Yuting
- Stevanus Juanda
- Tham Mun Hon
- Thanawat Thangchadakorn
Regional Morning Meeting Notes: Thursday, February 27, 2025
GREATER CHINA Economics Hong Kong Budget 2025-26 The budget balances fiscal discipline with strategic growth initiatives. Results ASMPT (522 HK/BUY/HK$64.05/Target: HK$80.00) 4Q24: Earnings disappoint; mainstream tools recovering in 2025 but visibility remains low. Maintain BUY. Budweiser APAC (1876 HK/BUY/HK$8.66/Target: HK$13.30) 4Q24: Results miss slightly; CEO change and increased shareho...
ASM PACIFIC TECHNOLOGY LIMITED
544 CSE GLOBAL LTD.
C09 CITY DEVELOPMENTS LIMITED
UNTR PT UNITED TRACTORS TBK
1155 MALAYAN BANKING BHD.
O39 OVERSEA-CHINESE BANKING CORPORATION LIMITED
CENTEL CENTRAL PLAZA HOTEL
ASII PT ASTRA INTERNATIONAL TBK
SAWAD SRISAWAD CORPORATION PUBLIC COMPANY LTD
AXIATA AXIATA GROUP BERHAD
HLBK HONG LEONG BANK BERHAD
SWB SUNWAY BHD
TXG 10X GENOMICS INC CLASS A
FEH FOOD EMPIRE HOLDINGS LTD
01876 BUDWEISER BREWING CO. APAC LTD.
BTG BETAGRO PUBLIC COMPANY LIMITED
- Benjaphol Suthwanish
Bangkok Dusit Medical Services (BDMS TB) - Decent Growth Expected In 4...
We expect BDMS to report a net profit of Bt4.1b in 4Q24 (+4.8% yoy, -2.5% qoq). The key drivers are decent growth from Thai patients and robust growth from foreign patients, especially from China and the Middle East. We should see a revised guidance for growth in 2025 and more details on the Wellness & Residence project in the upcoming analyst meeting. The co-payment insurance condition set to be launched should have minimal impact on BDMS. Maintain BUY. Target price: Bt33.00.
- Benjaphol Suthwanish
- Kampon Akaravarinchai
- Benjaphol Suthwanish
- Jonathan Koh
- Kampon Akaravarinchai
- Kong Ho Meng
- Stevanus Juanda
Regional Morning Meeting Notes: Friday, January 31, 2025
INDONESIA Update Mayora Indah (MYOR IJ/HOLD/Rp2,500/Target: Rp2,300) Margins will still be negatively affected in 4Q24 and 1H25. MALAYSIA Sector Oil & Gas PAO aligns with our view on cuts in exploration/JU rig demand, but maintenance demand remains intact. Plant turnaround may be the biggest winner, but with high execution risks in 2Q25, 2Q26 and 1Q27. SINGAPORE Sector REITs ...
BJC BERLI JUCKER PUBLIC CO. LTD.
5681 PETRONAS DAGANGAN BHD.
5218 SAPURA ENERGY BHD
AJBU KEPPEL DC REIT
MYOR MAYORA INDAH
3816 MISC BHD
5243 VELESTO ENERGY
UZMA UZMA BHD
YNS YINSON HOLDINGS BHD
KREIT KEPPEL REIT
BAB BUMI ARMADA BERHAD
MINT MAPLETREE INDUSTRIAL TRUST
DLG DIALOG GROUP BHD
MMHE MALAYSIA MARINE AND HEAVY EN
DLUM DELEUM BERHAD
TXG 10X GENOMICS INC CLASS A
ANE CORPORACION ACCIONA ENERGIAS RENOVABLES SA
CLAR CAPITALAND ASCENDAS REIT
DCRU DIGITAL CORE REIT MANAGEMENT PTE. LTD.
Z29 029 GROUP SE
- Jonathan Koh
- Philip Wong
- Posmarito Pakpahan
- Shirley Wang Xueyi
- Singapore Research Team
- Stella Guo Yuting
- Tham Mun Hon
- Thanawat Thangchadakorn
Regional Morning Meeting Notes: Thursday, January 02, 2025
GREATER CHINA Economics PMI A strong rebound for non-manufacturing PMI. Sector Macau Gaming Dec 24 GGR below expectations; expect 2025 GGR to recover to 82% of 2019’s level. INDONESIA Update Mitra Keluarga Karyasehat (MIKA IJ/BUY/Rp2,540/Target: Rp3,300) Expect a double-digit earnings growth in 2025 MALAYSIA Sector Heal...
KKP KIATNAKIN BANK
OU8 CENTURION
FCT FRASERS CENTREPOINT TRUST
5225 IHH HEALTHCARE BHD.
BBL BANGKOK BANK PUBLIC COMPANY LIMITED
544 CSE GLOBAL LTD.
7090 APEX HEALTHCARE
KTB KRUNG THAI BANK PUBLIC CO. LTD.
V03 VENTURE CORPORATION LIMITED
U96 SEMBCORP INDUSTRIES LTD.
B8O YANGZIJIANG SHIPBUILDING (HOLDINGS) LTD.
TISCO TISCO FINANCIAL GROUP
N2IU MAPLETREE COMMERCIAL TRUST
AJBU KEPPEL DC REIT
BUOU FRASERS LOGISTICS & COMMERCIAL TRUST
00027 GALAXY ENTERTAINMENT GROUP LIMITED
TMB TMB BANK PUBLIC COMPANY LIMITED
KBANK KASIKORNBANK PUBLIC CO. LTD.
C61U CAPITALAND COMMERCIAL TRUST
BH BUMRUNGRAD HOSPITAL PUBLIC CO. LTD.
O39 OVERSEA-CHINESE BANKING CORPORATION LIMITED
599A SANDS CHINA LTD.
BCH BANGKOK CHAIN HOSPITAL PCL
Q5T FAR EAST HOSPITALITY TRUST
MIKA MITRA KELUARGA KARYASEHAT
SATS SP SATS LTD.
G13 GENTING SINGAPORE LIMITED
CDREIT CDL HOSPITALITY TRUSTS
KREIT KEPPEL REIT
MLT MAPLETREE LOGISTICS TRUST
PREIT PARKWAYLIFE REAL ESTATE
KPJ KPJ HEALTHCARE BERHAD
MINT MAPLETREE INDUSTRIAL TRUST
RFMD RAFFLES MEDICAL GROUP LTD
SASSR SASSEUR REAL ESTATE INVESTMENT TRUST
TXG 10X GENOMICS INC CLASS A
DBB DUOPHARMA BIOTECH BHD
TGIF 1933 INDUSTRIES
ELITE ELITE COMMERCIAL REIT
UHU UNITED HAMPSHIRE US REIT
MPM MARCO POLO MARINE LTD
CSSC CHINA SUNSINE CHEMICAL HOLDINGS LTD
LREIT SP LENDLEASE GLOBAL COMMERCIAL REIT
OXMU PRIME US REIT
HMN ASCOTT RESIDENCE TRUST
CLCT CAPITALAND CHINA TRUST
KORE KEPPEL PACIFIC OAK US REIT
AMOKD 3DX INDUSTRIES INC
CVL CIVMEC
TSVT 2SEVENTY BIO INC
SCB SCB X PUBLIC COMPANY LIMITED
BCOW 1895 BANCORP OF WISCONSIN INC
CLAR CAPITALAND ASCENDAS REIT
AL2SI 2CRSI SA
DCRU DIGITAL CORE REIT MANAGEMENT PTE. LTD.
STM SEATRIUM LTD
Z29 029 GROUP SE
0303 ALPHA IVF GROUP
- Benjaphol Suthwanish
Bangkok Dusit Medical Services (BDMS TB) - 3Q24: Record-high Earnings ...
BDMS delivered a strong net profit of Bt4.2b in 3Q24 (+9.1% yoy, +27.3% qoq), which is in line with our and consensus’ estimates. The growth is contributed by a robust increase in Thai and international patient revenue. We find it impressive that BDMS is able to show growth from Middle East patients given the struggles of other hospital operators. We are optimistic with the growth outlook BDMS of going into the high travel season. Maintain BUY. Target price: Bt33.00.
- Benjaphol Suthwanish
- Kampon Akaravarinchai
- Kasemsun Koonnara
- Kitpon Praipaisarnkit
- Thanawat Thangchadakorn
Thailand Daily - Wednesday, November 13, 2024
KEY HIGHLIGHTS Results AP Thailand (AP TB/BUY/Bt8.60/Target: Bt11.30) 3Q24: Results meet expectations; strong backlog supports 4Q24 earnings. Bangkok Dusit Medical Services (BDMS TB/BUY/Bt26.50/Target: Bt33.00) 3Q24: Record-high earnings delivered. BTG TB (BTG TB/BUY/Bt20.10/Target: Bt24.20) 3Q24: Earnings in line. GFPT (GFPT TB/BUY/Bt10.80/Target: Bt13.00) 3Q24: Earnings in line; strong 4Q24 ea...
- Benjaphol Suthwanish
Bangkok Dusit Medical Services (BDMS TB) - Expecting A Record-high Qua...
BDMS should report a strong net profit of Bt4.2b in 3Q24 (+9.1% yoy, +27.3% qoq), mainly due to the increase in patient volume during the rainy season and the growth in international patient volume. Despite the slight impact from the flood in the north in 3Q24, we are optimistic going forward as there is potential upside from the delayed treatment of patients who could not gain access to hospitals due to the flood. Maintain BUY. Target price: Bt32.00.
- Benjaphol Suthwanish
- Kampon Akaravarinchai
- Tanaporn Visaruthaphong
Thailand Daily - Wednesday, October 30, 2024
KEY HIGHLIGHTS Results Home Product Center (HMPRO TB/HOLD/Bt9.65/Target: Bt11.00) 3Q24: Earnings in line; unexciting outlook with unappealing valuation. Downgrade to HOLD. SCGP (SCGP TB/HOLD/Bt25.50/Target: Bt26.00) 3Q24: Net profit below our and consensus estimates. Update Bangkok Dusit Medical Services (BDMS TB/BUY/Bt28.25/Target: Bt32.00) Expecting a record-high quarter in 3Q24.
- Benjaphol Suthwanish
Bangkok Dusit Medical Services (BDMS TB) - Embrace The Low Season And ...
The tone of BDMS’ analyst meeting in reviewing its 2Q24 results was positive. Despite being in the low season, BDMS still posted a decent yoy growth. Management implemented effective and promising strategies in order to improve BDMS’ performance. We are positive on the company’s prospect which is poised to see a more outstanding growth in the upcoming high season in 3Q24. Maintain BUY. Target price: Bt32.00.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.